Elicio TherapeuticsELTX
13F holders, Q1 2024 (March 31)18holders
1famous investor
$7.58avg. 13F price*
At the end of Q1 2024, 18 institutions reported holding Elicio Therapeutics Inc. (ELTX) in their 13F filings. The largest holders were Vanguard Group Inc. ($1.6M), CM Management, LLC ($570K) and Geode Capital Management, LLC ($363K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Elicio Therapeutics Inc.
- CUSIP
- 28657F103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $184K |
| Exits | 4 | $136K |
Ownership 18 holders
| Vanguard Group Inc. | 0.00% | Add +23.3% | 215,686 | $1.6M |
| CM Management, LLC | 0.48% | Add +50.0% | 75,000 | $570K |
| Geode Capital Management, LLC | 0.00% | Add +7.6% | 47,696 | $363K |
| State Street Corp. | 0.00% | New | 17,600 | $134K |
| Meyer Handelman Co. | 0.00% | No change | 13,899 | $106K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 12,500 | $95K |
| Renaissance Technologies | 0.00% | Reduce -28.6% | 11,761 | $89K |
| CIBC Private Wealth Group LLC | 0.00% | New | 7,000 | $43K |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 1,554 | $12K |
| Bank of America Corp. | 0.00% | Reduce -0.3% | 1,146 | $9K |
| BlackRock Inc. | 0.00% | No change | 917 | $7K |
| National Bank of Canada | 0.00% | New | 700 | $6K |
| Citigroup Inc. | 0.00% | No change | 374 | $3K |
| Northwest Capital Management Inc | 0.00% | No change | 350 | $3K |
| Avion Wealth | 0.00% | New | 78 | $1K |
| Morgan Stanley | 0.00% | Reduce -17.2% | 130 | $988 |
| Wells Fargo & Company | 0.00% | Add +16.3% | 50 | $380 |
| UBS Group AG | 0.00% | No change | 16 | $122 |
"% of holder's portfolio" is ELTX's weight in each manager's 13F, not the share of Elicio Therapeutics Inc. the manager owns.